113 related articles for article (PubMed ID: 38262371)
21. Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction.
Löfman I; Szummer K; Dahlström U; Jernberg T; Lund LH
Eur J Heart Fail; 2017 Dec; 19(12):1606-1614. PubMed ID: 28371075
[TBL] [Abstract][Full Text] [Related]
22. Cardiopulmonary exercise testing as prognostic indicators: Comparisons among heart failure patients with reduced, mid-range and preserved ejection fraction.
Sato T; Yoshihisa A; Kanno Y; Suzuki S; Yamaki T; Sugimoto K; Kunii H; Nakazato K; Suzuki H; Saitoh SI; Ishida T; Takeishi Y
Eur J Prev Cardiol; 2017 Dec; 24(18):1979-1987. PubMed ID: 29086584
[TBL] [Abstract][Full Text] [Related]
23. Empagliflozin in Heart Failure With Predicted Preserved Versus Reduced Ejection Fraction: Data From the EMPA-REG OUTCOME Trial.
Savarese G; Uijl A; Lund LH; Anker SD; Asselbergs F; Fitchett D; Inzucchi SE; Koudstaal S; Ofstad AP; Schrage B; Vedin O; Wanner C; Zannad F; Zwiener I; Butler J
J Card Fail; 2021 Aug; 27(8):888-895. PubMed ID: 34364665
[TBL] [Abstract][Full Text] [Related]
24. Significance of Ischemic Heart Disease in Patients With Heart Failure and Preserved, Midrange, and Reduced Ejection Fraction: A Nationwide Cohort Study.
Vedin O; Lam CSP; Koh AS; Benson L; Teng THK; Tay WT; Braun OÖ; Savarese G; Dahlström U; Lund LH
Circ Heart Fail; 2017 Jun; 10(6):. PubMed ID: 28615366
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of hyponatremia among ambulatory patients with heart failure and preserved and reduced ejection fractions.
Bavishi C; Ather S; Bambhroliya A; Jneid H; Virani SS; Bozkurt B; Deswal A
Am J Cardiol; 2014 Jun; 113(11):1834-8. PubMed ID: 24837261
[TBL] [Abstract][Full Text] [Related]
26. Role of ejection fraction in patients at risk for advanced heart failure: insights from the HELP-HF registry.
Pagnesi M; Lombardi CM; Tedino C; Chiarito M; Stolfo D; Baldetti L; Adamo M; Calì F; Inciardi RM; Tomasoni D; Loiacono F; Maccallini M; Villaschi A; Gasparini G; Montella M; Contessi S; Cocianni D; Perotto M; Barone G; Merlo M; Cappelletti AM; Sinagra G; Pini D; Metra M
ESC Heart Fail; 2024 Feb; 11(1):136-146. PubMed ID: 37845829
[TBL] [Abstract][Full Text] [Related]
27. Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcome.
Farmakis D; Simitsis P; Bistola V; Triposkiadis F; Ikonomidis I; Katsanos S; Bakosis G; Hatziagelaki E; Lekakis J; Mebazaa A; Parissis J
Clin Res Cardiol; 2017 May; 106(5):359-368. PubMed ID: 27999929
[TBL] [Abstract][Full Text] [Related]
28. Prognostic impacts of changes in left ventricular ejection fraction in heart failure patients with preserved left ventricular ejection fraction.
Yoshihisa A; Sato Y; Kanno Y; Takiguchi M; Yokokawa T; Abe S; Misaka T; Sato T; Oikawa M; Kobayashi A; Yamaki T; Kunii H; Takeishi Y
Open Heart; 2020; 7(1):e001112. PubMed ID: 32341787
[TBL] [Abstract][Full Text] [Related]
29. Tobacco smoking in patients with heart failure and coronary artery disease: A 20-year experience at Duke University Medical Center.
Grubb AF; Pumill CA; Greene SJ; Wu A; Chiswell K; Mentz RJ
Am Heart J; 2020 Dec; 230():25-34. PubMed ID: 32980363
[TBL] [Abstract][Full Text] [Related]
30. Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and preserved ejection fraction: a report from 14 964 patients in the European Society of Cardiology Heart Failure Long-Term Registry.
Zafrir B; Lund LH; Laroche C; Ruschitzka F; Crespo-Leiro MG; Coats AJS; Anker SD; Filippatos G; Seferovic PM; Maggioni AP; De Mora Martin M; Polonski L; Silva-Cardoso J; Amir O;
Eur Heart J; 2018 Dec; 39(48):4277-4284. PubMed ID: 30325423
[TBL] [Abstract][Full Text] [Related]
31. Sex Differences in Clinical Characteristics and 2-Year Prognosis of Patients with Heart Failure Grouped by Left Ventricular Ejection Fraction Status.
Wang C; Zhou Y; Zhong R; Bao Y; Li Z; Tian J
Int Heart J; 2020 Nov; 61(6):1236-1244. PubMed ID: 33191350
[TBL] [Abstract][Full Text] [Related]
32. Heart Failure and Midrange Ejection Fraction: Implications of Recovered Ejection Fraction for Exercise Tolerance and Outcomes.
Nadruz W; West E; Santos M; Skali H; Groarke JD; Forman DE; Shah AM
Circ Heart Fail; 2016 Apr; 9(4):e002826. PubMed ID: 27009553
[TBL] [Abstract][Full Text] [Related]
33. Hemoglobin to red cell distribution width ratio: A predictor of clinical outcome and diuretic response in patients with acute heart failure.
Chen H; Zhen Z; Dong Y; Liu C; Dong B; Xue R
Int J Cardiol; 2024 Jan; 394():131368. PubMed ID: 37739043
[TBL] [Abstract][Full Text] [Related]
34. Recovered heart failure with reduced ejection fraction and outcomes: a prospective study.
Lupón J; Díez-López C; de Antonio M; Domingo M; Zamora E; Moliner P; González B; Santesmases J; Troya MI; Bayés-Genís A
Eur J Heart Fail; 2017 Dec; 19(12):1615-1623. PubMed ID: 28387002
[TBL] [Abstract][Full Text] [Related]
35. Long-Term Prognostic Significance of Plasma B-Type Natriuretic Peptide Level in Patients With Acute Heart Failure With Reduced, Mid-Range, and Preserved Ejection Fractions.
Hamatani Y; Nagai T; Shiraishi Y; Kohsaka S; Nakai M; Nishimura K; Kohno T; Nagatomo Y; Asaumi Y; Goda A; Mizuno A; Yasuda S; Ogawa H; Yoshikawa T; Anzai T;
Am J Cardiol; 2018 Mar; 121(6):731-738. PubMed ID: 29394996
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of, associations with, and prognostic role of anemia in heart failure across the ejection fraction spectrum.
Savarese G; Jonsson Å; Hallberg AC; Dahlström U; Edner M; Lund LH
Int J Cardiol; 2020 Jan; 298():59-65. PubMed ID: 31521440
[TBL] [Abstract][Full Text] [Related]
37. Mortality associated with heart failure with preserved vs. reduced ejection fraction in a prospective international multi-ethnic cohort study.
Lam CSP; Gamble GD; Ling LH; Sim D; Leong KTG; Yeo PSD; Ong HY; Jaufeerally F; Ng TP; Cameron VA; Poppe K; Lund M; Devlin G; Troughton R; Richards AM; Doughty RN
Eur Heart J; 2018 May; 39(20):1770-1780. PubMed ID: 29390051
[TBL] [Abstract][Full Text] [Related]
38. Association of the classification and severity of heart failure with the incidence of contrast-induced acute kidney injury.
Xu T; Lin M; Shen X; Wang M; Zhang W; Zhao L; Li D; Luan Y; Zhang W
Sci Rep; 2021 Jul; 11(1):15348. PubMed ID: 34321588
[TBL] [Abstract][Full Text] [Related]
39. Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population.
Cheng RK; Cox M; Neely ML; Heidenreich PA; Bhatt DL; Eapen ZJ; Hernandez AF; Butler J; Yancy CW; Fonarow GC
Am Heart J; 2014 Nov; 168(5):721-30. PubMed ID: 25440801
[TBL] [Abstract][Full Text] [Related]
40. Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry.
Chioncel O; Lainscak M; Seferovic PM; Anker SD; Crespo-Leiro MG; Harjola VP; Parissis J; Laroche C; Piepoli MF; Fonseca C; Mebazaa A; Lund L; Ambrosio GA; Coats AJ; Ferrari R; Ruschitzka F; Maggioni AP; Filippatos G
Eur J Heart Fail; 2017 Dec; 19(12):1574-1585. PubMed ID: 28386917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
